- Tempest Therapeutics press release (NASDAQ:TPST): FY GAAP EPS of -$1.91 beats by $0.03.
- Tempest ended the year with $39.2 million in cash and cash equivalents, compared to $31.2 million on December 31, 2022.
- The increase was primarily due to proceeds from the issuance of common stock of $35.6 million from the at-the-market offering program, offset by cash used in operating activities.
Tempest Therapeutics GAAP EPS of -$1.91 beats by $0.03
Recommended For You
More Trending News
About TPST Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| TPST | - | - |
| Tempest Therapeutics, Inc. | ||